Eli Lilly and Company v. Genentech, Inc.
2:13-cv-07248
Overview
Parties
Defendant
Counter Defendant
Third Party Plaintiff
Court & Judges
Court
District Court, C.D. California (cacd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.
Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.
Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc. et al.
Genzyme Corporation et al. v. GENENTECH, INC. et al.
GENZYME CORPORATION et al. v. Genentech Inc. et al.
Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.
Genentech, Inc. v. Immunex Rhode Island Corp.
Genentech, Inc. v. Samsung Bioepis Co., Ltd.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
| US6331415 |
Filed: —
Issued: —
|
Term Verification Pending
Expires: —
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).
Procedural Motions & Interlocutory Orders
Total Motions
119
Dispositive
73
Granted
23
Denied
6
Pending / Review
90
Motions by Category
Key Dispositive Motions & Rulings